S. Strobel

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial

Robert E. Ratner, Richard A. Dickey, Mark Fineman et al. · Diabetic Medicine · 2004 · 307 citations

Medicine, Endocrinology, Pharmacotherapy +17

Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes

Priscilla Hollander, Philip T. Levy, Mark Fineman et al. · Diabetes Care · 2003 · 301 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

Ian Chapman, Barbara A. Parker, S. Doran et al. · Diabetologia · 2005 · 204 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +14

A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 Diabetes

Steve Edelman, Satish K. Garg, Juan P. Frías et al. · Diabetes Care · 2006 · 166 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Impact of Pramlintide on Glucose Fluctuations and Postprandial Glucose, Glucagon, and Triglyceride Excursions Among Patients With Type 1 Diabetes Intensively Treated With Insulin Pumps

Claresa Levetan, Laura L. Want, Christian Weyer et al. · Diabetes Care · 2003 · 155 citations · Full text

Medicine, Endocrinology, Pharmacology +17